Hepatoblastoma(HB)is the most common primary liver tumor in children and accounts for two-thirds of all malignant liver neoplasms in the pediatric population.Fo
AIM:To assess our experience with the use and management of everolimus-based regimens post-liver transplantation and to redefine the potential role of this drug